Comparative epidemiology of genetic lineages of Trypanosoma cruzi
Genomic approaches to metabolite exploitation from Xenorhabdus/Photorhabdus
Support for Clinical Trial Capacity Platform for Sleeping Sickness in Africa
New tools for monitoring drug resistance and treatment response in Visceral Leishmaniasis in the Indian subcontinent
Efficacy, acceptability and cost-effectiveness of long lasting insecticidal nets in the prevention of Kala-azar.
Targeting the Leishmania kinome for the development of novel anti-parasitic strategies
Development of a DNA vaccine for visceral Leishmaniasis
Control strategies for visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL) in South America: applications of molecular epidemiology.
Networking the networks for monitoring risk factors of (re-)emergence and spreading of leishmaniasis
Development of new tools to control infections due to parasites of the Trypanosomatidae family
Biology and clinical staging of trypanosome neuroinvasion in sleeping sickness
Syndromic approach to neglected infectious diseases (NID) at primary health care level: an international collaboration on integrated diagnosis-treatment platforms
PRe-clinicAl studies of a PSA-based human vaccine candidate targeting visceral, cutaneOus and mucocutaneous Leishmaniasis and Development of the associated procedures for further clinIcal trials
Nucleobase derivatives as drugs against trypanosomal diseases
Tsetse flies and the control of African sleeping sickness
Simplified rapid molecular diagnosis and characterisation of Leishmaniasis and Human African Trypanosomiasis